Liver Diseases  >>  ViraferonPeg (peginterferon-α-2b)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ViraferonPeg (peginterferon-α-2b) / Merck (MSD)
NCT00277758: Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I

Terminated
1
18
US
Interleukin 2, Proleukin, Ribavirin, Rebetrol, Pegylated Interferon Alpha, PEG-Intron, Inteleukin-2, Interferon-alpha, Ribavirin + Pegylated interferon-alpha
Weill Medical College of Cornell University, National Institute of Allergy and Infectious Diseases (NIAID)
Hepatitis C
07/06
08/06
NCT01081158: Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)

Completed
1
41
RoW
Drug: SCH 900518 Biologic: Peginterferon alfa-2b(PegIntron), narlaprevir, PegIntron, Drug: SCH 900518 Biologic: Peginterferon alfa-2b, Drug: SCH 900518 Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron), narlaprevir, norvir, PegIntron, Drug: SCH 900518 Drug: Ritonavir (RTV) Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron)
Merck Sharp & Dohme LLC
Hepatitis C, Chronic
08/08
08/08
NCT01547312: Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022)

Withdrawn
1
0
US
Peg-Interferon, PegIntron, Liver Samples from FNA, Liver Samples from CNB, Blood Samples, Ribavirin, Rebetol, 800 mg Grazoprevir, 100 mg Grazoprevir, Liver samples from CNB and FNA
Merck Sharp & Dohme LLC
Chronic Hepatitis C
11/12
11/12

Download Options